A Study to Evaluate the Safety, Pharmacokinetics of AD-118 and AD-1181 in Healthy Adult Subjects

Starting soon · Phase 1

Conditions studied: Chronic Heart Failure

In brief

A Study to Evaluate the Safety and Pharmacokinetics of AD-118 and AD-1181 Under Fasted Conditions in Healthy Adult Subjects

Key facts

Study ID

NCT07717749

Run by

Addpharma Inc.

People needed

74

Starts

2026-07-24

Expected to finish

2026-08-01

Last updated by the study team

2026-07-21

Who can join

Age: 19 and older, up to 64. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Body weight equal to or greater than 50kg and Body mass index (BMI) between 18.0 kg/m2 and 30.0 kg/m2 at the time of screening visit
• Subjects aged 19 years or older and under 65 years at the screening visit

You may not qualify if…

• Participation in another clinical study with an investigational drug within the 6 months from scheduled first administration
• Other exclusions applied

Where it is running

• H Plus Yangji Hospital — Seoul, South Korea

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.